» Articles » PMID: 36047965

Abnormality of Apico-basal Polarity in Adenocarcinoma

Overview
Journal Cancer Sci
Specialty Oncology
Date 2022 Sep 1
PMID 36047965
Authors
Affiliations
Soon will be listed here.
Abstract

Apico-basal polarity is a fundamental property of the epithelium that functions as a barrier, holds cells together, and determines the directions of absorption and secretion. Apico-basal polarity is regulated by extracellular matrix-integrin binding and downstream signaling pathways, including focal adhesion kinase, rouse-sarcoma oncogene (SRC), and RHO/RHO-associated kinase (ROCK). Loss of epithelial cell polarity plays a critical role in the progression of cancer cells. However, in differentiated carcinomas, polarity is not completely lost but dysregulated. Recent progress with a three-dimensional culture of primary cancer cells allowed for studies of the mechanism underlying the abnormality of polarity in differentiated cancers, including flexible switching of polarity status in response to the microenvironment. Invasive micropapillary carcinoma (MPC) is one of the histopathological phenotypes of adenocarcinoma, which is characterized by inverted polarity. Aberrant activation of RHO-ROCK signaling plays a critical role in the MPC phenotype. Establishing in vitro models will contribute to future drug targeting of the abnormal polarity status in cancer.

Citing Articles

Invasive micropapillary carcinoma of the breast and invasive breast carcinoma of no special type: a comparison of claudin proteins' expression and its impact on survival.

Kramer Z, Budai A, Pesti A, Kulka J, Tokes A Pathol Oncol Res. 2024; 30:1611987.

PMID: 39687048 PMC: 11646764. DOI: 10.3389/pore.2024.1611987.


Micropapillary structure: A natural tumor collective invasion model with enhanced stem-like properties.

Li S, Gao S, Qin L, Ding C, Qu J, Cui Y Cancer Sci. 2024; 116(2):308-321.

PMID: 39568148 PMC: 11786311. DOI: 10.1111/cas.16396.


Abnormality of apico-basal polarity in adenocarcinoma.

Onuma K, Inoue M Cancer Sci. 2022; 113(11):3657-3663.

PMID: 36047965 PMC: 9633284. DOI: 10.1111/cas.15549.

References
1.
Onuma K, Sato Y, Okuyama H, Uematsu H, Homma K, Ohue M . Aberrant activation of Rho/ROCK signaling in impaired polarity switching of colorectal micropapillary carcinoma. J Pathol. 2021; 255(1):84-94. DOI: 10.1002/path.5748. View

2.
Yang Y, Liu B, Zhang X, Fu L . Invasive Micropapillary Carcinoma of the Breast: An Update. Arch Pathol Lab Med. 2016; 140(8):799-805. DOI: 10.5858/arpa.2016-0040-RA. View

3.
Goehring N . PAR polarity: from complexity to design principles. Exp Cell Res. 2014; 328(2):258-66. DOI: 10.1016/j.yexcr.2014.08.009. View

4.
Bryant D, Mostov K . From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol. 2008; 9(11):887-901. PMC: 2921794. DOI: 10.1038/nrm2523. View

5.
Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I . Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas. Nat Cell Biol. 2018; 20(3):296-306. DOI: 10.1038/s41556-017-0027-6. View